Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in … (NCT06978075) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery
50 participantsStarted 2025-07-01
Plain-language summary
Chest wall tumors should be completely resection as much as possible while malignant chest wall tumors should be extensively resection. If not completely resection, it will recur in the short time and affect the patient's survival. At present, the surgical resection range mainly relies on preoperative imaging examination and the experience of the surgeon. It lacks precise guidance. This can easily lead to incomplete resection. In addition, the reconstruction materials required for reconstruct the excised chest wall defection are often generated in a standardized manner, lacking intraoperative adjustability. To address this clinical issue, we plan to carry out the research on the application of artificial Intelligence (AI) assisted chest wall tumor resection combined with personalized 3D preformed chest wall defection reconstruction system in chest wall tumor surgery.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 18-70 years old, male or female not limited
✓. Anesthesia ASA score I-II
✓. Malignant tumor of soft tissue in the chest
✓. Malignant tumors of ribs, rib cartilage, and sternum
✓. Tumors with uncertain or unknown properties of ribs, rib cartilage, and sternum
✓. Giant benign tumors of ribs, rib cartilage, and sternum
✓. The preoperative examination results indicate that the tumor has not undergone distant metastasis
✓. Willing to participate in the research and sign the informed consent form
Exclusion criteria
✕. Patients with distant metastasis detected during preoperative examination